Curis reported $2.35M in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
TG Therapeutics TGTX:US USD 92K 479K
Amgen AMGN:US USD 5.06B 20M
AstraZeneca AZN:LN USD 8.86B 3M
Bayer BAYN:GR EUR 7.03B 105M
Bristol Myers Squibb BMY:US USD 8.86B 345M
Chimerix CMRX:US USD 32.22M 31.78M
Eli Lilly And LLY:US USD 5.36B 305M
Exelixis EXEL:US USD 396.43M 9.51M
Gilead Sciences GILD:US USD 5.65B 829M
GlaxoSmithKline GSK:LN GBP 5.44B 650M
Merk MRK:US USD 11.52B 1.08B
Novartis NOVN:VX USD 9.18B 151M
Pfizer PFE:US USD 16.55B 2.52B
Takeda 4502:JP JPY 696.86B 17.28B
YTE INCY:US USD 774.02M 92.14M